Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

Hepatocellular carcinoma (HCC) remains a major global health problem and Calabria in the south of Italy is not an exception. Sorafenib is the first and only Food and Drug Administration approved drug for the treatment of advanced HCC and it is currently under intensive monitoring by the Health Autho...

Descripción completa

Detalles Bibliográficos
Autores principales: Cilurzo, Felisa, Staltari, Orietta, Patanè, Marinella, Ammendola, Michele, Garaffo, Caterina, Di Paola, Eugenio Donato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853677/
https://www.ncbi.nlm.nih.gov/pubmed/24347990
http://dx.doi.org/10.4103/0976-500X.120971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853677/
https://www.ncbi.nlm.nih.gov/pubmed/24347990
http://dx.doi.org/10.4103/0976-500X.120971

Ejemplares similares